brepocitinib
brepocitinib noun: an experimental medication belonging to the class of Janus kinase inhibitors.
Noun
brepocitinib (uncountable)
- An experimental medication belonging to the class of Janus kinase inhibitors.
- PF-06826647 is a TYK2-selective jakinib (68) currently in trials for the treatment of psoriasis, UC, and hidradenitis suppurativa; brepocitinib is a TYK2/JAK1 inhibitor that was assessed in a phase II trial of psoriasis where clinical responses were seen with all doses (69).2021 December, Christine Liu, Jacqueline Kieltyka, Roy Fleischmann, Massimo Gadina, John J. O’Shea, “A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?”, in Arthritis &...
Questions about brepocitinib
- What does brepocitinib mean?
- Brepocitinib means an experimental medication belonging to the class of Janus kinase inhibitors.
- What part of speech is brepocitinib?
- Brepocitinib is a noun.
Words near brepocitinib in the dictionary
Source and license
Adapted from Wiktionary: brepocitinib (page history and authors). Text available under the Creative Commons Attribution-ShareAlike 4.0 license. Word.ws reformatted the entry and added links. Wiktionary data of 2026-09-02.
Last updated:
Cite this entry: “brepocitinib.” Word.ws, https://word.ws/brepocitinib. Based on Wiktionary, CC BY-SA 4.0.
